Metformin Aurobindo

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformin Aurobindo (Metformin Hydrochloride)

Q: What is Metformin Aurobindo used for?

Metformin Aurobindo is an oral biguanide indicated for the management of type 2 diabetes mellitus. It helps lower elevated blood glucose levels by improving insulin sensitivity and reducing hepatic glucose production.

Q: How does Metformin Hydrochloride work?

Metformin Hydrochloride reduces hepatic gluconeogenesis, enhances peripheral insulin sensitivity, and modestly decreases intestinal glucose absorption. These actions lower circulating glucose without stimulating insulin release, providing effective glycaemic control.

Q: What determines the dose of Metformin Aurobindo?

The appropriate dose of Metformin Aurobindo is determined by the prescribing healthcare professional based on the patient’s renal function, glycaemic targets, and individual response. Dosage regimens are not disclosed here and should follow the prescriber’s instructions.

Q: Is Metformin Aurobindo safe during pregnancy or breastfeeding?

Metformin Aurobindo is classified as pregnancy category unknown. It should only be used during pregnancy or lactation if the potential benefit outweighs any possible risk, and this decision must be made by a qualified healthcare provider.

Q: How do I order Metformin Aurobindo from GNH India?

To order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does Metformin compare with other antidiabetic drugs?

Metformin is the first‑line oral agent for type 2 diabetes because it improves insulin sensitivity and has a low risk of hypoglycaemia compared with sulfonylureas or insulin. Unlike some newer agents, it does not cause weight gain and is generally well‑tolerated.

Q: How should Metformin Aurobindo be stored and handled?

Store Metformin Aurobindo at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Q: How is Metformin Aurobindo administered?

Metformin Aurobindo is taken orally, usually with meals to minimise gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water; they are not intended for crushing, chewing, or dissolving.

Q: What are the most serious risks to watch for with Metformin Aurobindo?

The most serious adverse events are lactic acidosis and severe hypoglycaemia, especially when combined with insulin or sulfonylureas. Prompt medical attention is required if patients experience unexplained muscle pain, rapid breathing, abdominal pain, or extreme fatigue.

Q: Who should not use Metformin Aurobindo?

Metformin Aurobindo should be avoided in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in those who have experienced lactic acidosis while on metformin.

Metformin Hydrochloride, the active ingredient in Metformin Aurobindo, is a biguanide presented as an oral tablet for oral use. It lowers elevated blood glucose levels and is indicated for the management of type 2 diabetes mellitus in adult patients.

GNH India supplies Metformin Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import and distribution. Its global network enables reliable delivery to diverse healthcare settings across the European Union and beyond.

Manufacturer / TM Owner

Aurobindo Pharma (Malta) Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin Aurobindo, a biguanide antidiabetic agent, is employed to improve glucose metabolism in several related conditions.

Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose.
Prediabetes (impaired glucose tolerance): helps delay progression to overt type 2 diabetes when combined with lifestyle measures.
Polycystic ovary syndrome: reduces insulin resistance and may aid in menstrual regularity.

How It Works

Metformin Hydrochloride acts primarily by inhibiting hepatic gluconeogenesis, thereby decreasing endogenous glucose production. It also enhances peripheral insulin sensitivity in muscle and adipose tissue, facilitating glucose uptake. Additionally, the drug modestly reduces intestinal absorption of glucose. These combined actions result in lower circulating blood glucose levels without stimulating insulin secretion. Metformin also activates AMP‑activated protein kinase (AMPK), which contributes to its metabolic effects and may improve lipid profiles.

Side Effects

Metformin Aurobindo may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea.
Metallic taste: transient alteration in taste perception.
Vitamin B12 deficiency: reduced absorption with long‑term use.
Weight loss: modest decrease in body weight.

Serious or Rare Side Effects

Lactic acidosis: rare but life‑threatening metabolic acidosis.
Severe hypoglycemia: usually when combined with insulin or sulfonylureas.
Hepatic dysfunction: elevated liver enzymes or hepatitis.

Precautions & Warnings

When prescribing Metformin Aurobindo, several precautions should be observed to ensure patient safety.

Renal function assessment: evaluate creatinine clearance before initiation and periodically.
Contraindication in severe renal impairment: avoid use if eGFR <30 mL/min/1.73 m².
Monitor for lactic acidosis: watch for unexplained acidosis, especially after surgery or in hypoxic states.
Vitamin B12 monitoring: consider periodic testing during long‑term therapy.
Pregnancy and lactation: use only if potential benefit justifies potential risk.
Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Metformin Aurobindo can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

Iodinated radiographic contrast media: can precipitate acute renal failure and increase risk of lactic acidosis; discontinue metformin before and after the procedure.
Renal‑toxic drugs (e.g., aminoglycosides, NSAIDs): may impair renal function, raising metformin concentrations.

Moderate Interactions (Monitor Closely)

Sulfonylureas or insulin: additive hypoglycaemic effect; monitor blood glucose closely.
Cimetidine or other CYP450 inhibitors: may increase metformin plasma levels.
Oral corticosteroids: may elevate blood glucose, requiring possible dose adjustment.

Frequently Asked Questions

Metformin Aurobindo is an oral biguanide indicated for the management of type 2 diabetes mellitus. It helps lower elevated blood glucose levels by improving insulin sensitivity and reducing hepatic glucose production.

Metformin Hydrochloride reduces hepatic gluconeogenesis, enhances peripheral insulin sensitivity, and modestly decreases intestinal glucose absorption. These actions lower circulating glucose without stimulating insulin release, providing effective glycaemic control.

The appropriate dose of Metformin Aurobindo is determined by the prescribing healthcare professional based on the patient’s renal function, glycaemic targets, and individual response. Dosage regimens are not disclosed here and should follow the prescriber’s instructions.

Metformin Aurobindo is classified as pregnancy category unknown. It should only be used during pregnancy or lactation if the potential benefit outweighs any possible risk, and this decision must be made by a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin is the first‑line oral agent for type 2 diabetes because it improves insulin sensitivity and has a low risk of hypoglycaemia compared with sulfonylureas or insulin. Unlike some newer agents, it does not cause weight gain and is generally well‑tolerated.

Store Metformin Aurobindo at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Metformin Aurobindo is taken orally, usually with meals to minimise gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water; they are not intended for crushing, chewing, or dissolving.

The most serious adverse events are lactic acidosis and severe hypoglycaemia, especially when combined with insulin or sulfonylureas. Prompt medical attention is required if patients experience unexplained muscle pain, rapid breathing, abdominal pain, or extreme fatigue.

Metformin Aurobindo should be avoided in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in those who have experienced lactic acidosis while on metformin.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.